Highlights From IASLC

Explore curated coverage of select research presented at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer.

The PD-L1 inhibitor durvalumab showed an overall survival benefit in patients with unresectable stage III non–small cell lung cancer (NSCLC) in the phase 3 PACIFIC trial.



Entrectinib achieved high response rates as well as durable responses in patients with ROS1-positive non–small cell lung cancer (NSCLC), including patients with brain metastases, according to a pooled analysis of phase 1 and 2 trials.

Atezolizumab combined with carboplatin/etoposide represents a new standard of care for first-line treatment of extensive-stage small cell lung cancer (ES-SCLC), according to results from the phase 3 IMpower133 trial presented at the IASLC 19th World Conference on Lung Cancer.

Brigatinib significantly prolonged survival compared with crizotinib (standard of care) as first-line therapy in patients with advanced anaplastic lymphoma kinase (ALK)-positive non–small cell lung cancer (NSCLC).

In the delivery of survivorship programs, oncology nurses have a duty to the person as whole, not just to their cancer.

Preoperative thoracic surgery education increases patient satisfaction and decreases patient anxiety and readmission rates associated with postoperative complications, all while optimizing overall outcomes for thoracic surgery patients, according to Katherine O. Kuhns, CRNP, a nurse practitioner specialist in thoracic surgery at the University of Pennsylvania Penn Presbyterian Medical Center.

Remote monitoring can improve quality of care and patient outcomes in the management of people with cancer, according to Roma Maguire, PhD, MSc, BN, RGN.

Progress has been made in lung cancer treatment, but as patients are living longer, addressing the toxicities of their systemic therapy is becoming increasingly paramount. In this field of patient management, oncology nurses play a vital role, according to Tanja Cufer, MD, PhD, a medical oncologist and Professor of Oncology at Medical Faculty, University of Ljubljana, Slovenia, and Senior Counselor at the University Clinic in Golnik, Slovenia.

Page 1 of 2

Journal of Oncology Navigation & Survivorship
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country